Vaneck Vectors Pharmaceutical etf shares owned by Prime Capital Investment Advisors
Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by Prime Capital Investment Advisors
from 13F filings
Historical chart of Prime Capital Investment Advisors investment in Vaneck Vectors Pharmaceutical etf
Tip: Access up to 7 years of quarterly data
All positions including Vaneck Vectors Pharmaceutical etf held by Prime Capital Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Vaneck Vectors Pharmaceutical etf by Prime Capital Investment Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $12M | 129k | 95.03 |
2024-06-30 | $12M | 134k | 91.48 |
2024-03-31 | $13M | 140k | 90.70 |
2023-12-31 | $12M | 142k | 81.37 |
2023-09-30 | $12M | 148k | 79.86 |
2023-06-30 | $12M | 146k | 78.77 |
2022-12-31 | $12M | 152k | 77.74 |
More positions owned by Prime Capital Investment Advisors
View all positions for Prime Capital Investment Advisors
Top funds holding Vaneck Vectors Pharmaceutical etf
View all funds holding Vaneck Vectors Pharmaceutical etf